Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism.

Chronis thromboembolic pulmonary hypertension Computed tomography angiography Pulmonary artery Pulmonary embolism Pulmonary hypertension

Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 19 05 2021
accepted: 27 09 2021
revised: 05 09 2021
pubmed: 3 12 2021
medline: 17 3 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

Closer reading of computed tomography pulmonary angiography (CTPA) scans of patients presenting with acute pulmonary embolism (PE) may identify those at high risk of developing chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to validate the predictive value of six radiological predictors that were previously proposed. Three hundred forty-one patients with acute PE were prospectively followed for development of CTEPH in six European hospitals. Index CTPAs were analysed post hoc by expert chest radiologists blinded to the final diagnosis. The accuracy of the predictors using a predefined threshold for 'high risk' (≥ 3 predictors) and the expert overall judgment on the presence of CTEPH were assessed. CTEPH was confirmed in nine patients (2.6%) during 2-year follow-up. Any sign of chronic thrombi was already present in 74/341 patients (22%) on the index CTPA, which was associated with CTEPH (OR 7.8, 95%CI 1.9-32); 37 patients (11%) had ≥ 3 of 6 radiological predictors, of whom 4 (11%) were diagnosed with CTEPH (sensitivity 44%, 95%CI 14-79; specificity 90%, 95%CI 86-93). Expert judgment raised suspicion of CTEPH in 27 patients, which was confirmed in 8 (30%; sensitivity 89%, 95%CI 52-100; specificity 94%, 95%CI 91-97). The presence of ≥ 3 of 6 predefined radiological predictors was highly specific for a future CTEPH diagnosis, comparable to overall expert judgment, while the latter was associated with higher sensitivity. Dedicated CTPA reading for signs of CTEPH may therefore help in early detection of CTEPH after PE, although in our cohort this strategy would not have detected all cases. • Three expert chest radiologists re-assessed CTPA scans performed at the moment of acute pulmonary embolism diagnosis and observed a high prevalence of chronic thrombi and signs of pulmonary hypertension. • On these index scans, the presence of ≥ 3 of 6 predefined radiological predictors was highly specific for a future diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH), comparable to overall expert judgment. • Dedicated CTPA reading for signs of CTEPH may help in early detection of CTEPH after acute pulmonary embolism.

Identifiants

pubmed: 34854928
doi: 10.1007/s00330-021-08364-0
pii: 10.1007/s00330-021-08364-0
pmc: PMC8921171
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2178-2187

Subventions

Organisme : Hartstichting
ID : 2017T064

Informations de copyright

© 2021. The Author(s).

Références

Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124:1973–1981
doi: 10.1161/CIRCULATIONAHA.110.015008
Huisman MV, Barco S, Cannegieter SC et al (2018) Pulmonary embolism. Nat Rev Dis Primers 4:18028
doi: 10.1038/nrdp.2018.28
Boon GJAM, van den Hout WB, Barco S et al (2021) A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension. ERJ Open Res 7:00719–02020. https://doi.org/10.1183/23120541.00719-2020:00719-02020
doi: 10.1183/23120541.00719-2020:00719-02020 pubmed: 34853780 pmcid: 8628742
Klok FA, Barco S, Konstantinides SV et al (2018) Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry. Eur Respir J 52(6):1801687
Guerin L, Couturaud F, Parent F et al (2014) Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 112:598–605
doi: 10.1160/TH13-07-0538
Lorenz G, Saeedan MB, Bullen J et al (2020) CT-based biomarkers for prediction of chronic thromboembolic pulmonary hypertension after an acute pulmonary embolic event. AJR Am J Roentgenol. https://doi.org/10.2214/AJR.19.22541:1-7
Rogberg AN, Gopalan D, Westerlund E, Lindholm P (2019) Do radiologists detect chronic thromboembolic disease on computed tomography? Acta Radiol 60:1576–1583
doi: 10.1177/0284185119836232
Ende-Verhaar YM, Meijboom LJ, Kroft LJM et al (2019) Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study. J Heart Lung Transplant 38:731–738
doi: 10.1016/j.healun.2019.03.003
Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A et al (2017) Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 49:1601792
Delcroix M, Torbicki A, Gopalan D et al (2021) ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 57:2002828 
Boon GJAM, Ende-Verhaar YM, Bavalia R et al (2021) Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study. Thorax 76:1002–1009
doi: 10.1136/thoraxjnl-2020-216324
Ende-Verhaar YMRD, Bogaard HJ, Huisman MV, Meijboom L, Vonk Noordegraaf A, Klok FA (2018) Sensitivity of a simple non-invasive screening algorithm for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. TH Open 2:e89–e95
doi: 10.1055/s-0038-1636537
Klok FA, Dzikowska-Diduch O, Kostrubiec M et al (2016) Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost 14:121–128
doi: 10.1111/jth.13175
Klok FA, Surie S, Kempf T et al (2011) A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res 128:21–26
doi: 10.1016/j.thromres.2011.03.004
Klok FA, Tesche C, Rappold L et al (2015) External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Res 135:796–801
doi: 10.1016/j.thromres.2014.12.009
Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 69:177
Rajaram S, Swift AJ, Condliffe R et al (2015) CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax 70:382–387
doi: 10.1136/thoraxjnl-2014-206088
Grosse A, Grosse C, Lang I (2018) Evaluation of the CT imaging findings in patients newly diagnosed with chronic thromboembolic pulmonary hypertension. PLoS One 13:e0201468
doi: 10.1371/journal.pone.0201468
Gopalan D, Delcroix M, Held M (2017) Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26:160108
Klok FA, Couturaud F, Delcroix M, Humbert M (2020) Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur Respir J 55:2000189
Braams NJ, Boon GJAM, de Man FS, et al (2021) Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of CTEPH. Eur Resp J 2100699. https://doi.org/10.1183/13993003.00699-2021
Konstantinides SV, Meyer G, Becattini C et al (2019) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respir J 54:1901647
doi: 10.1183/13993003.01647-2019
Ende-Verhaar YM, van den Hout WB, Bogaard HJ et al (2018) Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost 16:2168–2174
doi: 10.1111/jth.14266
Tapson VF, Platt DM, Xia F et al (2016) Monitoring for pulmonary hypertension following pulmonary embolism: The INFORM Study. Am J Med 129:978-985.e972
doi: 10.1016/j.amjmed.2016.03.006
Boon GJAM, Jairam PM, Groot GMC et al (2021) Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise. Eur J Intern Med. https://doi.org/10.1016/j.ejim.2021.07.001
doi: 10.1016/j.ejim.2021.07.001 pubmed: 34294517
Zhai Z, Staring M, Zhou X et al (2019) Linking convolutional neural networks with graph convolutional networks: application in pulmonary artery-vein separation. Springer International Publishing, Cham, pp 36–43
Remy-Jardin M, Faivre J-B, Kaergel R et al (2020) Machine learning and deep neural network applications in the thorax: pulmonary embolism, chronic thromboembolic pulmonary hypertension, aorta, and chronic obstructive pulmonary disease. J Thorac Imaging Suppl 1:S40–S48. https://doi.org/10.1097/RTI.0000000000000492
doi: 10.1097/RTI.0000000000000492
Jimenez-Del-Toro O, Dicente Cid Y, Platon A et al (2020) A lung graph model for the radiological assessment of chronic thromboembolic pulmonary hypertension in CT. Comput Biol Med 125:103962
doi: 10.1016/j.compbiomed.2020.103962
Liu W, Liu M, Guo X et al (2020) Evaluation of acute pulmonary embolism and clot burden on CTPA with deep learning. Eur Radiol 30:3567–3575
doi: 10.1007/s00330-020-06699-8

Auteurs

Gudula J A M Boon (GJAM)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, LUMC, (C7Q-14), Albinusdreef 2, Postbus 9600, 2300 RC, Leiden, The Netherlands. g.j.a.m.boon@lumc.nl.

Yvonne M Ende-Verhaar (YM)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, LUMC, (C7Q-14), Albinusdreef 2, Postbus 9600, 2300 RC, Leiden, The Netherlands.

Ludo F M Beenen (LFM)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Johan Coolen (J)

Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.

Marion Delcroix (M)

Department of Pneumology, University Hospitals Leuven, Leuven, Belgium.

Marek Golebiowski (M)

Department of Clinical Radiology, Medical University of Warsaw, Warsaw, Poland.

Menno V Huisman (MV)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, LUMC, (C7Q-14), Albinusdreef 2, Postbus 9600, 2300 RC, Leiden, The Netherlands.

Albert T A Mairuhu (ATA)

Department of Internal Medicine, Haga Teaching Hospital, The Hague, The Netherlands.

Lilian J Meijboom (LJ)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Saskia Middeldorp (S)

Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Piotr Pruszczyk (P)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.

Cornelis J van Rooden (CJ)

Department of Radiology, Haga Teaching Hospital, Den Haag, The Netherlands.

Anton Vonk Noordegraaf (A)

Department of Pulmonology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Lucia J M Kroft (LJM)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Frederikus A Klok (FA)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, LUMC, (C7Q-14), Albinusdreef 2, Postbus 9600, 2300 RC, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH